The commercial landscape for biosimilars: Planning in an uncertain environment
Arthur G Cook
Intellectual property and regulatory interplay in biosimilars
Christoph Volpers
Intellectual property and regulatory interplay in biosimilars
Christoph Volpers
How AbbVie tries to fend off world’s blockbuster No 1 from generic competition
Ulrich Storz
Innovative, cost effective solution for self-administration of bio-similar drugs
Tsachi Shaked
Journal of Bioanalysis & Biomedicine received 3099 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 